Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

55
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
55
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

48
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
48
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

69
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
69
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

49
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
49
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

251
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
251
Acute Pharyngitis01:30

Acute Pharyngitis

2.3K
Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alpha-gal Immunoglobulin E Seroprevalence Among Blood Donors - 10 States, 2024-2025.

MMWR. Morbidity and mortality weekly report·2026
Same author

Opinion: Ecologists and entomologists wanted! An open invitation to alpha-gal syndrome research.

Ticks and tick-borne diseases·2025
Same author

Ecologic Risk Factors for Infestation of Rhipicephalus sanguineus s.l. in a Rocky Mountain Spotted Fever-Endemic Area of Eastern Arizona.

The American journal of tropical medicine and hygiene·2025
Same author

Zoonoses in the workplace: A Seroprevalence study of <i>Coxiella</i>, <i>Brucella</i>, and <i>Leptospira</i> among marine mammal rescue and rehabilitation workers in California.

Public health challenges·2025
Same author

Coxiella burnetii Infections Identified by Molecular Methods, United States, 2006-2023.

Emerging infectious diseases·2025
Same author

National Surveillance of Human Ehrlichiosis Caused by Ehrlichia ewingii, United States, 2013-2021.

Emerging infectious diseases·2025

Related Experiment Video

Updated: Nov 2, 2025

The Development of Lyophilized Loop-mediated Isothermal Amplification Reagents for the Detection of Coxiella burnetii
07:27

The Development of Lyophilized Loop-mediated Isothermal Amplification Reagents for the Detection of Coxiella burnetii

Published on: April 18, 2016

10.6K

Pediatric Q Fever.

Cara C Cherry1, Gilbert J Kersh1

  • 1Rickettsial Zoonoses Branch, Centers for Disease Control and Prevention, 1600 Clifton Rd., Atlanta, GA 30329, USA.

Current Infectious Disease Reports
|June 17, 2021
PubMed
Summary

Diagnosing Q fever in children is challenging due to non-specific symptoms. Early recognition and treatment are crucial to prevent severe chronic complications from Coxiella burnetii infections.

Area of Science:

  • Pediatric Infectious Diseases
  • Bacteriology
  • Public Health

Background:

  • Q fever, caused by Coxiella burnetii, presents non-specifically in children, complicating diagnosis.
  • Untreated acute Q fever can progress to severe chronic infections with significant health implications.

Purpose of the Study:

  • To review the current understanding of pediatric Q fever.
  • To highlight diagnostic challenges and treatment strategies for Coxiella burnetii infections in children.

Main Methods:

  • Literature review of pediatric Q fever cases.
  • Analysis of reported treatment protocols and outcomes for Coxiella burnetii infections.

Main Results:

  • Pediatric Q fever cases are infrequently reported, often involving persistent Coxiella burnetii infections.
Keywords:
ChildrenCoxiella burnetiiPediatricQ fever

More Related Videos

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction
04:25

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction

Published on: February 24, 2014

46.1K
Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins
06:05

Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins

Published on: September 30, 2014

13.8K

Related Experiment Videos

Last Updated: Nov 2, 2025

The Development of Lyophilized Loop-mediated Isothermal Amplification Reagents for the Detection of Coxiella burnetii
07:27

The Development of Lyophilized Loop-mediated Isothermal Amplification Reagents for the Detection of Coxiella burnetii

Published on: April 18, 2016

10.6K
Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction
04:25

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction

Published on: February 24, 2014

46.1K
Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins
06:05

Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins

Published on: September 30, 2014

13.8K
  • No standardized treatment protocols for chronic pediatric Q fever exist; doxycycline and hydroxychloroquine are commonly used.
  • Adjunctive therapies like interferon gamma have shown mixed results.

    • Conclusions:

    • Q fever (both acute and chronic) is underreported and underdiagnosed in pediatric populations.
    • The long-term health impact of Coxiella burnetii in children requires further investigation.
    • Consider Q fever in pediatric patients presenting with culture-negative endocarditis or osteomyelitis.